Lista de obras -

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

artículo científico publicado en 2012

Acupuncture and temporomandibular disorders: a 3-month follow-up EMG study

artículo científico publicado en 2009

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain

artículo científico publicado en 2013

Acute effects of ayahuasca in a juvenile non-human primate model of depression

scientific article published on 08 November 2018

Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

artículo científico publicado en 2011

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala

artículo científico publicado en 2011

Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain

artículo científico

Age and gender influence on maximal bite force and masticatory muscles thickness

artículo científico publicado en 2010

Agomelatine in the treatment of social anxiety disorder

artículo científico publicado en 2010

Alterations in the stomatognathic system due to amyotrophic lateral sclerosis.

artículo científico publicado en 2018

Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder ⬇️

artículo científico publicado el 12 de marzo de 2011

An Overview of Animal Models Related to Schizophrenia

artículo científico publicado en 2018

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.

artículo científico publicado en 2015

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

artículo científico publicado en 2016

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

artículo científico publicado en 2016

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

artículo científico publicado en 2010

Arthur Bispo do Rosário (1909?-1989): insanity and art.

artículo científico publicado en 2009

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities

artículo científico publicado en 2017

Assessment of referrals to an OT consultation-liaison service: a retrospective and comparative study ⬇️

artículo científico publicado el 25 de noviembre de 2010

Ayahuasca Alters Structural Parameters of the Rat Aorta.

artículo científico publicado en 2015

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users

artículo científico publicado en 2019

Ayahuasca intoxication

artículo científico publicado en 2017

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

artículo científico publicado en 2017

Ayahuasca: Psychological And Physiologic Effects, Pharmacology And Potential Uses In Addiction And Mental Illness.

artículo científico publicado en 2018

Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study

artículo científico publicado en 2017

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

scientific article published on 21 August 2018

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

artículo científico publicado en 2016

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

artículo científico publicado en 2018

Cannabidiol monotherapy for treatment-resistant schizophrenia

artículo científico publicado en 2006

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

artículo científico publicado en 2017

Cannabinoids for the treatment of mental disorders

Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review

artículo científico

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.

artículo científico publicado en 2016

Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports

artículo científico publicado en 2013

Cross-cultural adaptation of the Internet Gaming Disorder Scale - Short Form (IGDS9-SF) to the Brazilian context

scientific article published on 21 August 2020

Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery?

artículo científico publicado en 2009

Dr Harley Quinn, the villain from Gotham City with dependent personality disorder – psychiatry in pictures

scholarly article by José Alexandre de Souza Crippa & Jaime Eduardo Cecilio Hallak published April 2012 in British Journal of Psychiatry

Effectiveness of olanzapine for systemic lupus erythematosus-related psychosis

artículo científico publicado en 2006

Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.

artículo científico publicado en 2016

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

artículo científico publicado en 2013

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination

artículo científico publicado en 2020

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

artículo científico publicado en 2009

Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial

artículo científico publicado en 2014

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

artículo científico publicado en 2009

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

artículo científico publicado en 2014

Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia

artículo científico publicado en 2014

Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.

artículo científico publicado en 2016

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

scientific article published on 23 August 2018

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

artículo científico publicado en 2015

Evaluation of molar and incisor bite force in indigenous compared with white population in Brazil

artículo científico publicado en 2007

Functional neuroimaging of minocycline's effect in a patient with schizophrenia

artículo científico publicado en 2010

Gender differences and the effects of ketamine in healthy volunteers.

artículo científico publicado en 2004

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder

artículo científico publicado en 2006

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study

artículo científico publicado en 2008

Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case report ⬇️

artículo científico publicado el 1 de marzo de 2012

Increased amygdalar and hippocampal volumes in young adults with social anxiety

artículo científico publicado en 2014

Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study

artículo científico publicado en 2005

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

artículo científico publicado en 2017

Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

artículo científico publicado en 2019

Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions

artículo científico publicado en 2010

Late-onset social anxiety disorder following traumatic brain injury

artículo científico publicado en 2012

Letter to the Editor

artículo científico publicado en 2015

Lipoma adhered to the corpus callosum in a schizophrenic patient with severe positive symptoms that responded to clozapine

artículo científico publicado en 2002

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

artículo científico publicado en 2015

Marijuana, feijoada and the debate on drug legalization

artículo científico publicado en 2013

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

artículo científico publicado en 2012

Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder

scientific article published on 01 October 2019

National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health

artículo científico publicado en 2010

Neuroimaging correlates of pharmacological and psychological treatments for specific phobia

artículo científico publicado en 2014

Neuroimaging in social anxiety disorder: a systematic review of the literature

artículo científico publicado en 2010

Neuroimaging in specific phobia disorder: a systematic review of the literature

artículo científico publicado en 2012

Neuroimaging of depression in Parkinson's disease: a review

artículo científico publicado en 2013

Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings

artículo científico publicado en 2017

New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems

artículo científico publicado en 2010

Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis.

artículo científico

Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.

artículo científico publicado en 2015

Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy

artículo científico publicado en 2003

Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task

artículo científico publicado en 2014

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).

artículo científico publicado en 2010

Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?

artículo científico publicado en 2020

Proneness, urbanicity, trauma, and cannabis triggering psychotic states in large urban centers

artículo científico publicado en 2020

Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy

artículo científico publicado en 2017

Psychedelics and Personality

artículo científico publicado en 2018

Public Speaking in Social Phobia: A Pilot Study of Self‐Ratings and Observers' Ratings of Social Skills ⬇️

artículo científico publicado el 3 de febrero de 2012

Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study

artículo científico publicado en 2020

Quality of life in patients with Charcot-Marie-Tooth disease type 1A.

artículo científico publicado en 2013

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial

artículo científico publicado en 2020

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

artículo científico publicado en 2018

Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2013

Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report

artículo científico publicado en 2013

Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects

artículo científico publicado en 2020

Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases.

artículo científico publicado en 2016

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion

artículo científico publicado en 2011

Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials

scientific article published on 09 April 2020

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature

scientific article published on 26 April 2019

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer

artículo científico publicado en 2019

Serotonergic psychedelics and personality: A systematic review of contemporary research

artículo científico publicado en 2018

Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

artículo científico publicado en 2018

Sodium nitroprusside treatment of clozapine-refractory schizophrenia

artículo científico publicado en 2014

Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

artículo científico publicado en 2014

Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples

scientific article published on 29 April 2020

Sulpiride and refractory panic disorder

artículo científico publicado en 2012

Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia

scientific article published on 01 September 2011

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial

scientific article published on 19 November 2019

The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials

artículo científico publicado en 2020

The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study

scientific article published on 01 February 2015

The fast alcohol screening test (FAST) is as good as the AUDIT to screen alcohol use disorders

artículo científico publicado en 2010

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects

artículo científico publicado en 2010

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

artículo científico publicado en 2015

The quest for better diagnosis: DSM-5 or RDoC?

artículo científico publicado en 2013

The role of inflammation in schizophrenia: an overview

artículo científico publicado en 2015

Therapeutical use of the cannabinoids in psychiatry

artículo científico publicado en 2010

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

artículo científico publicado en 2016

Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)

artículo científico publicado en 2020

Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease

artículo científico publicado en 2013

Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease

artículo científico publicado en 2010

Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: Two questions and one important answer ⬇️

artículo científico publicado el 23 de mayo de 2011

Why we should use long-acting injectable antipsychotics more frequently

article

[Cannabis sativa: the plant that can induce unwanted effects and also treat them]

artículo científico publicado en 2010

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol

artículo científico publicado en 2016

Lista de obras de

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Acupuncture and temporomandibular disorders: a 3-month follow-up EMG study

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain

Acute effects of ayahuasca in a juvenile non-human primate model of depression

Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala

Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain

Age and gender influence on maximal bite force and masticatory muscles thickness

Agomelatine in the treatment of social anxiety disorder

Alterations in the stomatognathic system due to amyotrophic lateral sclerosis.

Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder ⬇️

An Overview of Animal Models Related to Schizophrenia

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

Arthur Bispo do Rosário (1909?-1989): insanity and art.

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities

Assessment of referrals to an OT consultation-liaison service: a retrospective and comparative study ⬇️

Ayahuasca Alters Structural Parameters of the Rat Aorta.

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users

Ayahuasca intoxication

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

Ayahuasca: Psychological And Physiologic Effects, Pharmacology And Potential Uses In Addiction And Mental Illness.

Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Cannabidiol monotherapy for treatment-resistant schizophrenia

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

Cannabinoids for the treatment of mental disorders

Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.

Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports

Cross-cultural adaptation of the Internet Gaming Disorder Scale - Short Form (IGDS9-SF) to the Brazilian context

Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery?

Dr Harley Quinn, the villain from Gotham City with dependent personality disorder – psychiatry in pictures

Effectiveness of olanzapine for systemic lupus erythematosus-related psychosis

Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia

Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Evaluation of molar and incisor bite force in indigenous compared with white population in Brazil

Functional neuroimaging of minocycline's effect in a patient with schizophrenia

Gender differences and the effects of ketamine in healthy volunteers.

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study

Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case report ⬇️

Increased amygdalar and hippocampal volumes in young adults with social anxiety

Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions

Late-onset social anxiety disorder following traumatic brain injury

Letter to the Editor

Lipoma adhered to the corpus callosum in a schizophrenic patient with severe positive symptoms that responded to clozapine

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

Marijuana, feijoada and the debate on drug legalization

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder

National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health

Neuroimaging correlates of pharmacological and psychological treatments for specific phobia

Neuroimaging in social anxiety disorder: a systematic review of the literature

Neuroimaging in specific phobia disorder: a systematic review of the literature

Neuroimaging of depression in Parkinson's disease: a review

Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings

New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems

Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis.

Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.

Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy

Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).